pyrazole has been researched along with Liver Cirrhosis in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, GH | 1 |
| Liu, J | 1 |
| Guo, FY | 1 |
| Zhang, ZH | 1 |
| Jiang, YJ | 1 |
| Lin, YC | 1 |
| Lan, XQ | 1 |
| Ren, J | 1 |
| Wu, YL | 1 |
| Nan, JX | 1 |
| Jin, CH | 1 |
| Lian, LH | 1 |
1 other study available for pyrazole and Liver Cirrhosis
| Article | Year |
|---|---|
The in vitro and in vivo study of a pyrazole derivative, J-1063, as a novel anti-liver fibrosis agent: Synthesis, biological evaluation, and mechanistic analysis.
Topics: Animals; Fibrosis; Liver Cirrhosis; Mice; Pyrazoles; Smad Proteins; Transforming Growth Factor beta | 2022 |